Proprietary AI analyst is now available

Concord Medical Services Valuation Multiples

Discover revenue and EBITDA valuation multiples for Concord Medical Services and similar public comparables like Maternus-Kliniken, Clinica de Marly, Emyria, Eukedos and more.

Concord Medical Services Overview

About Concord Medical Services

Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.


Founded

2007

HQ

China

Employees

918

Website

ccm.cn

Financials (FY)

Revenue: $68M
EBITDA: ($11M)

EV

$515M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Concord Medical Services Financials

Concord Medical Services reported last fiscal year revenue of $68M and negative EBITDA of ($11M).

In the same fiscal year, Concord Medical Services generated $4M in gross profit, ($11M) in EBITDA losses, and had net loss of ($14M).


Concord Medical Services P&L

In the most recent fiscal year, Concord Medical Services reported revenue of $68M and EBITDA of ($11M).

Concord Medical Services is unprofitable as of last fiscal year, with gross margin of 6%, EBITDA margin of (16%), and net margin of (20%).

See analyst estimates for Concord Medical Services
Last FY202320242025202620272028
Revenue$68M$79M$57M$68M
Gross Profit$4M($11M)($12M)$4M
Gross Margin6%(14%)(21%)6%
EBITDA($11M)($39M)($51M)($11M)
EBITDA Margin(16%)(49%)(90%)(16%)
EBIT Margin(52%)(86%)(139%)(52%)
Net Profit($14M)($44M)($46M)($14M)
Net Margin(20%)(55%)(80%)(20%)
Net Debt$468M---

Financial data powered by Morningstar, Inc.

Concord Medical Services Stock Performance

Concord Medical Services has current market cap of $22M, and enterprise value of $515M.

Market Cap Evolution


Concord Medical Services' stock price is $5.06.

Concord Medical Services share price increased by 2.6% in the last 30 days, and decreased by 11.7% in the last year.

Concord Medical Services has an EPS (earnings per share) of $-3.16.

See more trading valuation data for Concord Medical Services
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$515M$22M12.2%2.6%31.8%-11.7%$-3.16

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Concord Medical Services Valuation Multiples

Concord Medical Services trades at 7.6x EV/Revenue multiple, and (48.6x) EV/EBITDA.

See NTM and 2027E valuation multiples for Concord Medical Services

Concord Medical Services Financial Valuation Multiples

As of June 5, 2026, Concord Medical Services has market cap of $22M and EV of $515M.

Concord Medical Services has a P/E ratio of (1.6x).

Last FY202320242025202620272028
EV/Revenue7.6x6.5x9.1x7.6x
EV/EBITDA(48.6x)(13.3x)(10.1x)(48.6x)
EV/EBIT(14.6x)(7.5x)(6.6x)(14.6x)
EV/Gross Profit135.1x(45.5x)(44.1x)135.1x
P/E(1.6x)(0.5x)(0.5x)(1.6x)
EV/FCF(11.9x)(8.8x)(4.3x)(11.9x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Concord Medical Services Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Concord Medical Services Margins & Growth Rates

In the most recent fiscal year, Concord Medical Services reported gross margin of 6%, EBITDA margin of (16%), and net margin of (20%).

See estimated margins and future growth rates for Concord Medical Services

Concord Medical Services Margins

Last FY20242025202720282029
Gross Margin6%(21%)6%
EBITDA Margin(16%)(90%)(16%)
EBIT Margin(52%)(139%)(52%)
Net Margin(20%)(80%)(20%)
FCF Margin(64%)(211%)(64%)

Concord Medical Services Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(29%)20%
Gross Profit Growth3%(133%)
EBITDA Growth32%(79%)
EBIT Growth15%(55%)
Net Profit Growth4%(70%)
FCF Growth104%(64%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Concord Medical Services Operational KPIs

Concord Medical Services' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Concord Medical Services
Last FY202320242025202620272028
Revenue per Employee$0.1M---
Opex per Employee$0.0M---
S&M Expenses to Revenue11%10%13%11%
G&A Expenses to Revenue46%61%105%46%
Opex to Revenue58%72%118%58%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Concord Medical Services Competitors

Concord Medical Services competitors include Maternus-Kliniken, Clinica de Marly, Emyria, Eukedos, Gesundheitswelt Chiemgau, MedNation, Speed Medical SAE, Amwill Healthcare, Sudmedica and Latvijas Juras medicinas.

Most Concord Medical Services public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Maternus-Kliniken1.7x-48.6x-
Clinica de Marly----
Emyria20.2x-(10.4x)-
Eukedos2.7x-12.8x-
Gesundheitswelt Chiemgau0.5x-4.9x-
MedNation0.4x-3.7x-
Speed Medical SAE----
Amwill Healthcare1.6x-5.6x-

This data is available for Pro users. Sign up to see all Concord Medical Services competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Concord Medical Services

When was Concord Medical Services founded?Concord Medical Services was founded in 2007.
Where is Concord Medical Services headquartered?Concord Medical Services is headquartered in China.
How many employees does Concord Medical Services have?As of today, Concord Medical Services has over 918 employees.
Who is the CEO of Concord Medical Services?Concord Medical Services' CEO is Jianyu Yang.
Is Concord Medical Services publicly listed?Yes, Concord Medical Services is a public company listed on NYSE.
What is the stock symbol of Concord Medical Services?Concord Medical Services trades under CCM ticker.
When did Concord Medical Services go public?Concord Medical Services went public in 2009.
Who are competitors of Concord Medical Services?Concord Medical Services main competitors include Maternus-Kliniken, Clinica de Marly, Emyria, Eukedos, Gesundheitswelt Chiemgau, MedNation, Speed Medical SAE, Amwill Healthcare, Sudmedica, Latvijas Juras medicinas.
What is the current market cap of Concord Medical Services?Concord Medical Services' current market cap is $22M.
What is the current revenue of Concord Medical Services?Concord Medical Services' last fiscal year revenue is $68M.
What is the current EV/Revenue multiple of Concord Medical Services?Current revenue multiple of Concord Medical Services is 7.6x.
Is Concord Medical Services profitable?No, Concord Medical Services is not profitable.
How many companies Concord Medical Services has acquired to date?Concord Medical Services hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Concord Medical Services has invested to date?Concord Medical Services hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Concord Medical Services

Lists including Concord Medical Services

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial